F Campos, M Alfonso, R Durán
Index: Neurochem. Int. 56(6-7) , 850-5, (2010)
Full Text: HTML
In vitro studies suggest that alpha7 nicotinic receptors located on striatal glutamatergic terminals stimulate the release of glutamate which in turn acts at ionotropic glutamate receptors on dopaminergic terminals to increase dopamine release. However, this mechanism has never been observed in in vivo studies. In the present work, the effect of the nicotinic receptors agonist, anatoxin-a, on striatal glutamate and dopamine release has been studied. Using in vivo microdialysis technique, our results have shown that anatoxin-a evokes glutamate release in a dependent way of activation alpha7 nicotinic receptors. The increase of glutamate is followed by an increase on dopamine levels. These results represent a clear in vivo evidence of the striatal modulation of dopamine by means of glutamate release through alpha7 nicotinic receptors.Copyright 2010 Elsevier Ltd. All rights reserved.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
trans-4-Carboxy-L-proline
CAS:64769-66-0 |
C6H9NO4 |
Evidence for a role of GABA- and glutamate-gated chloride ch...
2012-11-01 [Pharmacol. Biochem. Behav. 103(1) , 69-75, (2012)] |
Substituted pyrrolidine-2,4-dicarboxylic acid amides as pote...
2006-06-15 [Bioorg. Med. Chem. Lett. 16(12) , 3268-72, (2006)] |
The effects of local perfusion of DAMGO on extracellular GAB...
2008-02-01 [J. Neurochem. 104(3) , 806-17, (2008)] |
Effects of theanine, r-glutamylethylamide, on neurotransmitt...
2005-08-01 [Nutr. Neurosci. 8(4) , 219-26, (2005)] |
Dissociation between hippocampal neuronal loss, astroglial a...
2006-12-01 [Neurochem. Int. 49(7) , 691-7, (2006)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved